Novartis AG Other Current Payables
Novartis AG (NVSEF) had Other Current Payables of $1.29 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:OtherCurrentPayables · last filed 2026-02-04
- 2025-12-31: Other Current Payables $1.29B.
- 2024-12-31: Other Current Payables $1.37B; Other Current Payables as first filed $879.00M.
- 2023-12-31: Other Current Payables $820.00M.
- 2022-12-31: Other Current Payables $743.00M.
| Period end | Other Current Payables | Other Current Payables as first filed |
|---|---|---|
| 2025-12-31 | $1.29B 20-F · filed 2026-02-04 | |
| 2024-12-31 | $1.37B 20-F · filed 2026-02-04 | $879.00M 20-F · filed 2025-01-31 |
| 2023-12-31 | $820.00M 20-F · filed 2025-01-31 | |
| 2022-12-31 | $743.00M 20-F · filed 2024-01-31 | |
| 2021-12-31 | $588.00M 20-F/A · filed 2023-05-15 | |
| 2020-12-31 | $716.00M 20-F · filed 2022-02-02 | |
| 2019-12-31 | $764.00M 20-F · filed 2021-01-26 | |
| 2018-12-31 | $673.00M 20-F · filed 2020-01-29 | |
| 2017-12-31 | $897.00M 20-F · filed 2019-01-30 | $1.04B 6-K · filed 2018-01-24 |
| 2016-12-31 | $722.00M 6-K · filed 2018-01-24 |